← Back to Patent Explorer
US5567440A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods for modifying cell contact with a surface

Assignee: The University of Texas System
•
Filing: 1995-06-06
•
Granted: 1996-10-22
•
Expires: 2015-06-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Described herein is a multi-functional polymeric material for use in inhibiting adhesion and immune recognition between cells and cells, cells and tissues, and tissues and tissues. One component of the polymeric material adsorbs well to cells or tissue, and the other component of the polymeric material does not adsorb well to tissues. A water-soluble polymer that does not bear charge (polynonion) is used as the non-binding component, and a water soluble polymer that is positively charged at physiological pH (polycation) is used as the tissue binding component. When the bi-functional polymeric material contacts a tissue, the tissue-binding component binds and thus immobilizes the attached non-binding component, which will then extend generally away from the tissue surface and sterically block the attachment of other tissues. The method and compositions are useful in inhibiting formation of post-surgical adhesions, protecting damaged blood vessels from thrombosis and restenosis, and decreasing the extent of metastasis of attachment-dependent tumor cells.

Inventors

  • 👤 Jeffrey A. Hubbell
  • 👤 Donald Elbert
  • 👤 Jennifer L. Hill-West
  • 👤 Paul D. Drumbeller
  • 👤 Sanghamitra Chowdhury
  • 👤 Amarpreet Sawhney

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 11:48
CPC Classifications
C; C08; C08G; C08G81/00; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/62; A61K47/64; A61K47/645; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5031; A61K9/5073; A61L; A61L31/00; A61L31/04; A61L31/06

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 157 words
A method for modifying cell contact with a surface, comprising applying to the surface a biocompatible polymeric material which is selected from the group consisting of copolymers having the formulas (A)x(B)y; (A)x(B)y(A)z; (B)x(A)y(B)z; and a brush copolymer (A)x(B)y having bristles of poly(A); wherein (A)x, (A)y and (A)z are biocompatible synthetic polymers and mixtures of polymers that form a region which is polynonionic at a pH of between 6.5 and 8.5 and does not bind tissue; and wherein (B)y, (B)x, and (B)z are biocompatible, water-soluble synthetic polymers or mixture of polymers that form a region which is polycationic at a pH of between 6.5 and 8.5 and binds to tissue; and wherein x is an integer of greater than or equal to 5, y is an integer of greater than or equal to 3, and z is an integer of greater than or equal to 0; wherein the polymer has a molecular weight of at least 300 g/mole.
Claim 2
Independent Claim 157 words
A method for modifying cell contact with a surface, comprising applying to the surface a biocompatible polymeric material which is selected from the group consisting of copolymers having the formulas (A)x(B)y; (A)x(B)y(A)z; (B)x(A)y(B)z; and a brush copolymer (A)x(B)y having bristles of poly(A); wherein (A)x, (A)y and (A)z are biocompatible synthetic polymers and mixtures of polymers that form a region which is polynonionic at a pH of between 6.5 and 8.5 and does not bind tissue; and wherein (B)y, (B)x, and (B)z are biocompatible, water-soluble synthetic polymers or mixture of polymers that form a region which is polycationic at a pH of between 6.5 and 8.5 and binds to tissue; and wherein x is an integer of greater than or equal to 5, y is an integer of greater than or equal to 3, and z is an integer of greater than or equal to 0; wherein the polymer has a molecular weight of at least 300 g/mole.
Claim 3
Dependent Claim 19 words
The method of claim 1 wherein the a biocompatible polymeric material is a block copolymer having the formula (A)x(B)y.
Claim 4
Dependent Claim 27 words
The method of claim 1 wherein the polymeric material further comprises a region C that is subject to degradation in vivo by hydrolysis, enzymatic degradation, or oxidation.
Claim 5
Dependent Claim 26 words
The method of claim 1 wherein the tissue binding region (B)y converts to a non-tissue binding region when exposed to water, oxidation or to enzymatic attack.
Claim 6
Dependent Claim 26 words
The method of claim 1 wherein the non-tissue binding region (A)x converts to a tissue binding region when exposed to water, oxidation or to enzymatic attack.
Claim 7
Dependent Claim 20 words
The method of claim 1 wherein the polymeric material further comprises an agent which is biologically active in a patient.
Claim 8
Dependent Claim 34 words
The method of claim 1 wherein the surface is a tissue surface, and wherein the polymer is applied to the tissue surface to inhibit tissue adhesion, thrombus formation, restenosis, or metastasis at the surface.
Claim 9
Dependent Claim 20 words
The method of claim 7 wherein the surface is a region of a tissue surface that has been surgically cut.
Claim 10
Dependent Claim 41 words
The method of claim 1 wherein the surface is the lining of a damaged blood vessel, and wherein the polymer is applied to the surface to inhibit thrombosis or adhesion at the lining of a blood vessel that has been damaged.
Claim 11
Dependent Claim 30 words
The method of claim 1 wherein the surface is a tissue surface, and wherein the polymer is applied to the tissue surface to inhibit attachment of cancerous or tumor cells.
Claim 12
Dependent Claim 28 words
The method of claim 7 wherein the surface is injured tissue of an organ or lumen of the body which contacts other organs that have also been injured.
Claim 13
Dependent Claim 34 words
The method of claim 1 wherein the polymer further comprises an agent which is biologically active in a patient, and wherein the polymer is targeted to attach to specific cell types by the agent.
Claim 14
Dependent Claim 19 words
The method of claim 1 wherein the surface is a tissue surface that has been chemically fixed or cryopreserved.
Claim 15
Dependent Claim 46 words
The method of claim 1 wherein (A)x and (A)z are selected from the group consisting of poly(oxyalkylene oxides), poly(ethyloxazoline), poly(N-vinyl pyrrolidone), poly(vinyl alcohol), neutral poly(amino acids) and copolymers of monomers selected from the group consisting of oxyalkylene oxides, ethyloxazoline, N-vinyl pyrrolidone, vinyl alcohol, and amino acids.
Claim 16
Dependent Claim 31 words
The method of claim 1 wherein (B)y is selected from the group consisting of poly(ethyleneimine), quaternary amines, and polyamines having amine groups on either the polymer backbone or the polymer sidechains.
Claim 17
Dependent Claim 19 words
The method of claim 1 wherein the tissue binding region (B)y is formed by polymerization of amides or esters.
Claim 18
Dependent Claim 17 words
The method of claim 1 where the non-tissue binding region (A)x is polyanionic and soluble in water.
Claim 19
Dependent Claim 26 words
The method of claim 6 wherein the polymeric material is biodegradable, and the biologically active agent is a component which is released as the polymer degrades.
Claim 20
Dependent Claim 16 words
The method of claim 6 wherein the biologically active agent is chemically coupled to the polymer.
Claim 21
Dependent Claim 23 words
The method of claim 7 wherein the biocompatible polymeric material is applied to the tissue surface in combination with a pharmaceutically acceptable carrier.
Claim 22
Dependent Claim 34 words
The method of claim 1 wherein the surface is a tissue surface and wherein the application of the polymer to the surface inhibits the attachment of cancer cells or platelets to the tissue surface.
Claim 23
Dependent Claim 42 words
The method of claim 1 wherein the surface is the surface of a tissue at a site of injury to the tissue, and wherein the application of the polymer to the surface enhances the binding of epithelial cells to the injured site.
Claim 24
Dependent Claim 33 words
The method of claim 1 wherein the surface is selected from the group consisting of an injured blood vessel, a surgical anastomosis, an injured serosal surface, a corneal injury and a skin wound.
Claim 25
Dependent Claim 23 words
The method of claim 1 wherein the surface is selected from the group consisting of an injured tissue site and an implant surface.
Claim 26
Dependent Claim 36 words
The method of claim 1 wherein the surface is the surface of a second cell, and wherein the method comprises applying the polymer to the second cell thereby to inhibit or enhance contact of the cells.

References Cited (Backward Citations)

US4076800A Cited
US4352883A Cited
US4409331A Cited
US4434150A Cited
US4663268A Cited
US4808355A Cited
US4923645A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-10-22 2000-04-22 2000-10-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-10-22 2004-04-22 2004-10-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-10-22 2008-04-22 2008-10-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag